EI

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

EI

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

EI

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

EI

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

EI

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

Search

Orion Oyj (Class B)

Închisă

65.6 0.08

Rezumat

Modificarea prețului

24h

Curent

Minim

64.95

Maxim

65.9

Indicatori cheie

By Trading Economics

Venit

119M

180M

Vânzări

62M

417M

P/E

Medie Sector

25.093

35.733

EPS

0.59

Randament dividend

2.4

Marjă de profit

43.289

Angajați

3,700

EBITDA

202M

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.40%

3.13%

Statistici piață

By TradingEconomics

Capitalizare de piață

609M

9.5B

Deschiderea anterioară

65.52

Închiderea anterioară

65.6

Orion Oyj (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 sept. 2025, 23:59 UTC

Achiziții, Fuziuni, Preluări

Anglo American Is in Talks to Buy Teck Resources, Bloomberg Says

8 sept. 2025, 22:02 UTC

Principalele dinamici ale pieței

Microsoft Signs $17.4 Billion AI Deal With Nebius

8 sept. 2025, 17:01 UTC

Principalele dinamici ale pieței

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8 sept. 2025, 17:01 UTC

Principalele dinamici ale pieței

Tron Shares Rise After New Investment From Bravemorning

8 sept. 2025, 16:14 UTC

Principalele dinamici ale pieței

Beyond Air Shares Climb on FDA Orphan Drug Designation for Brain Cancer Treatment

8 sept. 2025, 16:13 UTC

Principalele dinamici ale pieței

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

8 sept. 2025, 23:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 sept. 2025, 23:12 UTC

Market Talk

Global Equities Roundup: Market Talk

8 sept. 2025, 23:12 UTC

Market Talk

Infratil's New Bull Likes Exposure to Growing Infrastructure Businesses -- Market Talk

8 sept. 2025, 22:56 UTC

Market Talk

Worst May Be Over for New Zealand Retailers -- Market Talk

8 sept. 2025, 22:23 UTC

Market Talk

Ebos's Near-Term Earnings Outlook Dims -- Market Talk

8 sept. 2025, 21:51 UTC

Market Talk

AT&T Backs Outlook After EchoStar Spectrum Purchase -- Market Talk

8 sept. 2025, 21:47 UTC

Principalele dinamici ale pieței

Microsoft Signs $17.4B AI Deal With Nebius

8 sept. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

This Quantum Pure Play Is Going Public. What Infleqtion Does Differently, Says Its CEO. -- Barrons.com

8 sept. 2025, 21:20 UTC

Achiziții, Fuziuni, Preluări

MEG Energy Plans to Respond on or Before Sept 15 >MEG.T

8 sept. 2025, 21:19 UTC

Achiziții, Fuziuni, Preluări

MEG Energy Special Committee and Board Will Evaluate Revised Strathcona Offer >MEG.T

8 sept. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

MEG Energy Acknowledges Strathcona's Intention to Revise Offer

8 sept. 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

8 sept. 2025, 19:33 UTC

Market Talk

Oil Futures Gain Despite Planned OPEC+ Output Increases -- Market Talk

8 sept. 2025, 19:22 UTC

Market Talk

U.S. Natural Gas Futures Settle Higher -- Market Talk

8 sept. 2025, 19:02 UTC

Market Talk

Dollar Lukewarm Amid Data Hiatus Ahead of August CPI -- Market Talk

8 sept. 2025, 18:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 sept. 2025, 18:24 UTC

Market Talk

Weaker Argentine Peso Profitable for Grain Producers -- Market Talk

8 sept. 2025, 17:29 UTC

Market Talk

Mexican Inflation Seen Little Changed in August -- Market Talk

8 sept. 2025, 16:59 UTC

Market Talk
Achiziții, Fuziuni, Preluări

SpaceX Spectrum Acquisition Will Create More Satellite Connection Supply, Verizon CEO Says -- Market Talk

8 sept. 2025, 16:36 UTC

Market Talk

Crude Futures Hold Gains After OPEC+ Output Decision -- Market Talk

8 sept. 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8 sept. 2025, 16:16 UTC

Câștiguri

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

8 sept. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 sept. 2025, 16:04 UTC

Market Talk

Global Equities Roundup: Market Talk

Comparație

Modificare preț

Orion Oyj (Class B) Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
help-icon Live chat